[1] Dong W, Zhu Y, Du Y, et al. Association between features of COPD and risk of venous thromboembolism[J]. Clin Respir J, 2019,13(8):499-504. [2] 李金玲,杨林瀛,庞桂芬,等.慢性阻塞性肺疾病急性加重期合并深静脉血栓形成的相关因素分析[J].医学与哲学,2016,37(549):39-41. [3] 王静,鲁月,龚娟妮,等.慢性阻塞性肺疾病急性加重合并静脉血栓栓塞症的临床特征、危险因素及早期识别研究[J].中国医刊,2018,53(10):1102-1106. [4] 刘翔,赵婷,毕俏杰,等. 急诊重症监护病房慢性阻塞性肺疾病老年患者下肢深静脉血栓形成的发病特征及危险因素[J].中华老年学杂志,2019,39(13):3154-3156. [5] Pang H, Wang L, Liu J, et al. The prevalence and risk factors of venous thromboembolism in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease[J]. Clin Respir J,2018,12(11):2573-2580. [6] 崔亚,楠陈,平陈燕. 2018年版慢性阻塞性肺疾病全球倡议诊断及处理和预防策略解读[J].中华结核和呼吸杂志,2018,41(3):236-239. [7] 中华医学会外科学分会血管外科学组. 深静脉血栓形成的诊断和治疗指南(第三版)[J].中华普通外科杂志,2017,32(9):807-812. [8] 中华医学会心血管病学分会肺血管病学组. 急性肺栓塞诊断与治疗中国专家共识2015[J].中华心血管病杂志,2016,44(3):197-211. [9] Kim V, Goel N, Gangar J, et al. Risk factors for venous thromboembolism in chronic obstructive pulmonary disease[J]. Chronic Obstr Pulm Dis,2014,1(2):239-249. [10]阎锡新,陈荣昌, 柏长青,等.慢性阻塞性肺疾病急性加重抗感染治疗中国专家共识[J].国际呼吸杂志,2019,39(17):1281-1296. [11]王深明,景在平,陈忠,等. 深静脉血栓形成的诊断和治疗指南(第三版)[J].中华普通外科杂志,2017,32(9):807-812. [12]段林立,张挪富,刘春丽. 慢性阻塞性肺疾病急性加重合并静脉血栓栓塞症研究进展[J].中华结核和呼吸杂志,2016,39(2):130-133. [13]陈维,樊晶,艾娇,等.慢性阻塞性肺疾病急性加重患者肺栓塞的危险因素及Caprini血栓风险评估量表的预测价值[J].江苏大学学报,2019,29(2):142-146. [14]Liang L R, Zhang Z, Wang H, et al. Proportion and prevention of venous thromboembolism among hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Beijing[J]. Zhonghua Yi Xue Za Zhi, 2013,93(30):2337-2340. [15]朱春明,张鹤,郑锐.中性粒细胞/淋巴细胞比值、红细胞分布宽度与慢性阻塞性肺疾病急性加重的相关分析[J].中国医科大学学报,2018,47(4):312-315. [16]李德魁,王月光,张花,等.C反应蛋白在脊柱手术围手术期下肢深静脉血栓形成中的表达意义[J].中国骨与关节损伤杂志,2018,33(2):220-222. [17]李雪英,胡苏萍,陈国忠,等.炎症反应与慢性阻塞性肺疾病相关肺动脉高压及其血液高凝状态的关系[J].山东医药,2017,57(1):71-73. [18]张恒林,谢文凯,羊才丰,等.高敏C反应蛋白、白细胞介素-6、溶血磷脂酸及D-二聚体与下肢骨折后深静脉血栓形成的相关性研究[J].中华老年多器官疾病杂志,2018,17(4):292-296. [19]Matsuo H, Nakajima Y, Ogawa T, et al. Evaluation of D-dimer in screening deep vein thrombosis in hospitalized japanese patients with acute medical diseases/episodes[J]. Ann Vasc Dis,2016,9(3):193-200. [20]Akpinar E E, Hoşgün D, Dõganay B, et al. Should the cut-off value of D-dimer be elevated to exclude pulmonary embolism in acute exacerbation of COPD? [J]. J Thorac Dis, 2013,5(4):430-434. [21]陈俊先,温琼娜,孙兰春,等. COPD急性加重期并发静脉血栓栓塞症的发病情况及危险因素分析[J].广东医科大学学报,2018,36(5):527-530. |